title: [Role of beta-blockers in the pharmacologic treatment of congestive heart failure].
abstract: Beta-blockers are generally considered contra-indicated in heart failure. Some authors have claimed that in dilated cardiomyopathy and in pos myocardial infarction patients with heart failure beta-blockers can improve symptoms and survival. These trials and their conclusions are revised and the rationals of pathologic physiology of heart failure for this treatment are discussed.
authors.forename: A
authors.initials: A
authors.lastname: Longo
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000188:drug therapy*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists
vernacular_title: O lugar dos beta-bloqueantes na terapêutica farmacológica da insuficiência cardíaca congestiva.